Abstract
A complete axillary lymph node (ALN) dissection is therapeutic in node-positive breast cancer. Presently, there is no international consensus regarding anatomic levels to be addressed in complete axillary dissection. We assessed the burden of disease in level III axilla. A prospectively maintained database was assessed for 1,591 consecutive patients with nonmetastatic breast cancer registered at Tata Memorial Center, Mumbai, between January 2009 and December 2014. A median of four (zero to 20) level III ALNs were dissected and a median of two (one to 17) nodes were positive. A total of 27.3% (434 of 1,591) patients had level III ALN metastasis, and 4.7% of patients had positive interpectoral nodes. Some 53.2% of patients had level III metastases in the presence of four or more positive level I and II ALNs. A total of 9.4% of patients had level III involvement when one to three ALNs were positive in level I and II ( P < .001). Some 53.2% of patients had level III metastases in the presence of four or more positive level I and II ALNs. On logistic regression analysis, four or more positive ALNs in level I or II ( P < .001), inner/central quadrant tumor location ( P = .013), and perinodal extension ( P < .001) were associated with...Continue Reading
References
Jun 1, 1977·Cancer·B FisherR Lawton
May 15, 1992·Cancer·C I Kiricuta, J Tausch
Feb 15, 1987·Cancer·U VeronesiM Merson
Mar 14, 1985·The New England Journal of Medicine·B FisherR Foster
Mar 1, 1983·Annals of Surgery·P P RosenE J Beattie
Oct 15, 1981·Cancer·B FisherE R Fisher
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P P LinR R Baker
Feb 25, 1999·Annals of Surgical Oncology·R K Orr
Dec 28, 1999·American Journal of Surgery·A BaleF Fromowitz
Nov 20, 2002·ANZ Journal of Surgery·Boon ChuaJohn Boyages
Aug 9, 2003·The New England Journal of Medicine·Umberto VeronesiRoberto Gennari
Nov 20, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·B KuruH Alagol
Jan 13, 2004·The British Journal of Surgery·T TominagaM Danno
Dec 6, 2005·Cancer·Theodore KimGary H Lyman
May 4, 2006·Journal of the National Cancer Institute·Robert E ManselPeter J Ell
Aug 11, 2006·Journal of Surgical Oncology·Ajit PaiR A Badwe
Oct 4, 2006·British Journal of Cancer·H KodamaN Kan
Sep 14, 2007·The Lancet Oncology·David N KragUNKNOWN National Surgical Adjuvant Breast and Bowel Project
Oct 7, 2008·Cancer·Mangesh A ThoratRajendra A Badwe
Jul 22, 2010·Journal of Surgical Oncology·Takamaru AshikagaUNKNOWN National Surgical Adjuvant Breast, Bowel Project
Sep 25, 2010·The Lancet Oncology·David N KragNorman Wolmark
Nov 22, 2011·Journal of the Egyptian National Cancer Institute·Medhat KhafagyIbrahim Fakhr
May 10, 2012·World Journal of Surgery·Sarah PesekDavid Krag
Mar 8, 2013·The Surgical Clinics of North America·Dalliah M Black, Elizabeth A Mittendorf
Aug 21, 2013·The Breast : Official Journal of the European Society of Mastology·V ParmarR A Badwe
Oct 2, 2013·The Breast : Official Journal of the European Society of Mastology·Zhaoqing FanTao Ouyang
Mar 25, 2014·Lancet·P McGaleS Darby
Dec 3, 2014·The Lancet Oncology·Mila DonkerEmiel J T Rutgers